Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1986 Jul;58(3):467–471.

Loss of susceptibility to complement lysis in Entamoeba histolytica HM1 by treatment with human serum.

J Calderon, R Tovar
PMCID: PMC1453474  PMID: 2874111

Abstract

Entamoeba histolytica HM1, exposed to a series of treatment with normal human serum (NHS), progressively lost susceptibility to complement lysis. Trophozoites were incubated daily with unheated or heat-inactivated NHS for 2 hr at 36 degrees, starting with 10% v/v serum and increasing by 5% every 3 days up to 40% NHS. Resistance to complement lysis was also obtained with two different HM1 clones but not with the low virulent strain HK9. Induction of resistance dependent on the number of NHS treatments, with a maximal 50% reduction occurring after 11 treatments. Susceptibility to complement-dependent lysis was regained 6 weeks after serum treatments were terminated, suggesting that resistance to lysis was an acquired rather than a genetic property.

Full text

PDF
467

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calderon J., Schreiber R. D. Activation of the alternative and classical complement pathways by Entamoeba histolytica. Infect Immun. 1985 Nov;50(2):560–565. doi: 10.1128/iai.50.2.560-565.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Capin M. R., Jiménez M., Zamacona G., Ortíz-Ortíz L. Determinación de complemento y vía alterna del complemento en pacientes con absceso hepático amibiano. Arch Invest Med (Mex) 1978;9 (Suppl 1):297–302. [PubMed] [Google Scholar]
  3. Capin R., Capin N. R., Carmona M., Ortíz-Ortíz L. Effect of complement depletion on the induction of amebic liver abscess in the hamster. Arch Invest Med (Mex) 1980;11(1 Suppl):173–180. [PubMed] [Google Scholar]
  4. Diamond L. S., Harlow D. R., Cunnick C. C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431–432. doi: 10.1016/0035-9203(78)90144-x. [DOI] [PubMed] [Google Scholar]
  5. Engvall E., Jonsson K., Perlmann P. Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes. Biochim Biophys Acta. 1971 Dec 28;251(3):427–434. doi: 10.1016/0005-2795(71)90132-2. [DOI] [PubMed] [Google Scholar]
  6. Gillin F. D., Diamond L. S. Clonal growth of Entamoeba histolytica and other species of Entamoeba in agar. J Protozool. 1978 Nov;25(4):539–543. doi: 10.1111/j.1550-7408.1978.tb04182.x. [DOI] [PubMed] [Google Scholar]
  7. Huldt G., Davies P., Allison A. C., Schorlemmer H. U. Interactions between Entamoeba histolytica and complement. Nature. 1979 Jan 18;277(5693):214–216. doi: 10.1038/277214a0. [DOI] [PubMed] [Google Scholar]
  8. Immunoglobulin and complement levels in cases of invasive amoebiasis. Indian J Med Res. 1978 Feb;67:221–226. [PubMed] [Google Scholar]
  9. Krupp I. M., Powell S. J. Comparative study of the antibody response in amebiasis. Persistence after successful treatment. Am J Trop Med Hyg. 1971 May;20(3):421–424. doi: 10.4269/ajtmh.1971.20.421. [DOI] [PubMed] [Google Scholar]
  10. Lynch E. C., Rosenberg I. M., Gitler C. An ion-channel forming protein produced by Entamoeba histolytica. EMBO J. 1982;1(7):801–804. doi: 10.1002/j.1460-2075.1982.tb01250.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Maddison S. E., Kagan I. G., Elsdon-Dew R. Comparison of intradermal and serologic tests for the diagnosis of amebiasis. Am J Trop Med Hyg. 1968 Jul;17(4):540–547. doi: 10.4269/ajtmh.1968.17.540. [DOI] [PubMed] [Google Scholar]
  12. Muñoz M. L., Rojkind M., Calderón J., Tanimoto M., Arias-Negrete S., Martínez-Palomo A. Entamoeba histolytica: collagenolytic activity and virulence. J Protozool. 1984 Aug;31(3):468–470. doi: 10.1111/j.1550-7408.1984.tb02995.x. [DOI] [PubMed] [Google Scholar]
  13. Orozco E., Guarneros G., Martinez-Palomo A., Sánchez T. Entamoeba histolytica. Phagocytosis as a virulence factor. J Exp Med. 1983 Nov 1;158(5):1511–1521. doi: 10.1084/jem.158.5.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ortiz-Ortiz L., Capin R., Capin N. R., Sepúlveda B., Zamacona G. Activation of the alternative pathway of complement by Entamoeba histolytica. Clin Exp Immunol. 1978 Oct;34(1):10–18. [PMC free article] [PubMed] [Google Scholar]
  15. Reed S. L., Sargeaunt P. G., Braude A. I. Resistance to lysis by human serum of pathogenic Entamoeba histolytica. Trans R Soc Trop Med Hyg. 1983;77(2):248–253. doi: 10.1016/0035-9203(83)90083-4. [DOI] [PubMed] [Google Scholar]
  16. Sargeaunt P. G., Williams J. E. Electrophoretic isoenzyme patterns of the pathogenic and non-pathogenic intestinal amoebae of man. Trans R Soc Trop Med Hyg. 1979;73(2):225–227. doi: 10.1016/0035-9203(79)90219-0. [DOI] [PubMed] [Google Scholar]
  17. Young J. D., Young T. M., Lu L. P., Unkeless J. C., Cohn Z. A. Characterization of a membrane pore-forming protein from Entamoeba histolytica. J Exp Med. 1982 Dec 1;156(6):1677–1690. doi: 10.1084/jem.156.6.1677. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES